DOSSIER · 13F-HR · Q1 2026

Duquesne Family Office LLC

$3.4B in tracked AUM across 70 positions as of Q1 2026. Managed by Stanley Druckenmiller

DF
CIK 0001536411 · last filed Mar 31, 2026
Total AUM
$3.4B
as of Q1 2026
Holdings
70
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Stanley Druckenmiller's Duquesne Family Office trimmed its 13F book by nearly 25% quarter over quarter, from $4.5 billion to $3.4 billion, but the shrinkage wasn't broad-based selling — it was concentration. Natera grew from 12.8% to 18.1% of the portfolio as Duquesne added another 22% to its share count, cementing the genetic-testing stock as by far the largest single-name bet in a 70-position book. The other side of the ledger tells a rotation story: Duquesne exited its entire Select Sector SPDR Financial ETF stake ($301 million), sold out of Alphabet ($121 million) and MercadoLibre ($95 million) outright, and cut Amazon by 71% and Teva by 60% — while building a new Argentina-focused position (Global X's ARGT ETF) alongside a 433% jump in YPF, the Argentine state oil company, and a fresh 238% add to STMicroelectronics. Reading the quarter as a single move: money came out of US financials, mega-cap tech, and LatAm e-commerce, and went into a concentrated genetic-testing wager plus an outsized bet on Argentina's energy sector.

Natera is the throughline. Druckenmiller's firm already carried the genetic-testing company as its top position last quarter at 12.8% of assets; this quarter it added roughly 552,000 more shares (+22%), pushing NTRA to 18.1% of the book — nearly one dollar in five. No other position comes close: iShares' Brazil ETF (EWZ) sits a distant second at 8.7%, and Insmed, the next specific stock, is at 5.6%. A single-name weighting above 18% means Natera's next earnings print or regulatory update moves this portfolio's return more than any other event this quarter.

The exits are just as pointed. Duquesne closed out its entire $301 million Financial Select Sector SPDR (XLF) stake, sold its full $121 million Alphabet position, and liquidated $95 million of MercadoLibre — three complete exits spanning US financials, mega-cap tech, and Latin American e-commerce. Amazon survived but was cut 71% (to $51 million from $193 million), Teva was cut 60%, Coupang 61%, and Woodward 64%. None of these were trims; they were structural de-weightings.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q1 2026. Methodology

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
NTRA
Natera Inc
$613M3.1M18.1%
02
EWZ
Ishares Inc
$294M7.7M8.7%
03
INSM
Insmed Inc
$189M1.2M5.6%
04
TSM
Taiwan Semiconductor Manufac
$167M495K5.0%
05
RSP
Invesco Exchange Traded Fd T
$158M821K4.7%
06
YPF
Ypf Sociedad Anonima
$150M3.2M4.4%
07
G0896C103
Bbb Foods Inc
$110M3.1M3.3%
08
AA
Alcoa Corp
$99M1.5M2.9%
09
N62509109
Newamsterdam Pharma Company
$98M3.1M2.9%
10
SE
Sea Ltd
$91M1.1M2.7%

Filing history

2026Q1Mar 31
$3.4B 24.9%
70 positionsView →
2025Q4Dec 31
$4.5B 10.6%
62 positionsView →
2025Q3Sep 30
$4.1B 0.2%
65 positionsView →
2025Q2Jun 30
$4.1B 33.0%
69 positionsLocked
2025Q1Mar 31
$3.1B 17.8%
52 positionsLocked
2024Q4Dec 31
$3.7B 26.1%
78 positionsLocked
2024Q3Sep 30
$3.0B 1.2%
75 positionsLocked
2024Q2Jun 30
$2.9B 33.5%
64 positionsLocked
2024Q1Mar 31
$4.4B 30.9%
73 positionsLocked
2023Q4Dec 31
$3.4B 20.3%
51 positionsLocked
2023Q3Sep 30
$2.8B 3.1%
41 positionsLocked
2023Q2Jun 30
$2.9B 24.6%
53 positionsLocked
Showing 12 of 55